Bank of New York Mellon’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-69,673
Closed -$94.1K 4307
2026
Q1
$94.1K Sell
69,673
-8,781
-11% -$17.6K ﹤0.01% 4110
2025
Q4
$204K Sell
78,454
-36,265
-32% -$99.2K ﹤0.01% 4018
2025
Q3
$344K Buy
114,719
+8,342
+8% +$29.8K ﹤0.01% 3807
2025
Q2
$428K Buy
106,377
+14,835
+16% +$54.7K ﹤0.01% 3594
2025
Q1
$305K Sell
91,542
-14,344
-14% -$68.4K ﹤0.01% 3699
2024
Q4
$654K Buy
105,886
+17,521
+20% +$102K ﹤0.01% 3383
2024
Q3
$493K Sell
88,365
-5,953
-6% -$39.7K ﹤0.01% 3527
2024
Q2
$705K Buy
94,318
+34,999
+59% +$216K ﹤0.01% 3378
2024
Q1
$344K Sell
59,319
-5,271
-8% -$26.4K ﹤0.01% 3717
2023
Q4
$319K Buy
64,590
+18,491
+40% +$95.3K ﹤0.01% 3770
2023
Q3
$236K Buy
46,099
+626
+1% +$3.69K ﹤0.01% 3904
2023
Q2
$307K Buy
+45,473
New +$270K ﹤0.01% 3819

Other funds holding BTMD

Bank of New York Mellon's BTMD Position: Q2 2026 in Review

Bank of New York Mellon sold out of Biote Corp (BTMD) in Q2 2026, closing a stake of 69,673 shares — an estimated $94.1K sold.

Bank of New York Mellon first reported a position in BTMD in Q2 2023 and held it in 12 quarters. The position peaked at $705K in Q2 2024. 36 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.

  • Bank of New York Mellon reported no remaining Biote Corp position as of Q2 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 69,673 Biote Corp shares in Q2 2026, an estimated $94.1K.
  • Bank of New York Mellon first reported a position in Biote Corp in Q2 2023 and held it in 12 quarters.
  • Bank of New York Mellon's Biote Corp position peaked at $705K in Q2 2024.
  • 36 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.